Company profile
Perspective Therapeutics, Inc. Insider Trading
CATXEvery SEC Form 4 insider trading filing for Perspective Therapeutics, Inc. (CATX) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- NYSE
- Sector
- Pharmaceutical Preparations
- CIK
- 0000728387
- Filings
- 74
- Insiders
- 14
- Last filing
- 2026-09-04
Activity summary
Recent insider activity is bearish. Over the last 30 days, insiders net sold $1.6M across 7 transactions.
Three year balance
Buy and sell value by quarter, Q4 23 to Q3 26. Perspective Therapeutics, Inc. insiders are net buyers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $57.7M.
90 day insight
Over the last 90 days, Perspective Therapeutics, Inc. insiders sold $1.6M across 7 transactions with no open-market purchases.
- Most active insider: Lantheus Alpha Therapy, LLC with 5 transactions totaling $1.3M.
- Largest single sale: $526K by Lantheus Alpha Therapy, LLC on Sep 4, 2026.
Activity skews bearish — sales outpace buys.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 4, 2026 | Lantheus Alpha Therapy, LLC | CATX | Sale | 167,149 | $3.15 | $526K |
| Sep 3, 2026 | Lantheus Alpha Therapy, LLC | CATX | Sale | 80,783 | $3.11 | $251K |
| Sep 2, 2026 | Lantheus Alpha Therapy, LLC | CATX | Sale | 42,129 | $3.11 | $131K |
| Sep 1, 2026 | Lantheus Holdings, Inc. | CATX | Sale | 35,769 | $3.12 | $112K |
| Sep 1, 2026 | Lantheus Alpha Therapy, LLC | CATX | Sale | 35,769 | $3.12 | $112K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=CATX" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.
Institutional Ownership
Top 13F-HR holders of Perspective Therapeutics, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →